A B S T R A C T Serum inorganic pyrophosphate (PPi) levels were consistently two-to threefold higher than plasma PPi prepared from the same blood. PPi was found in platelets in amounts ranging from 1.4 to 3 nmol/108 cells, using three different techniques for quantification. These levels are approximately 800 times higher than the mean PPi concentration in normal plasma and approximate the levels of ADP found in platelets by other workers.
INTRODUCTION
We recently developed an isotopic dilution method for direct measurement of inorganic pyrophosphate (PPi) in biological fluids and tissues (1) . This was done to study pyrophosphate metabolism in calcium pyrophosphate crystal deposition disease (pseudogout syndrome; articular chondrocalcinosis) (2, 3) . During development of this technique it became obvious that serum contained two to three times as much PPi as did platelet-poor plasma prepared from the same blood. That platelets con-for all of these samples. PPi values were obtained in serum and platelet-poor plasma prepared from identical blood of healthy donors, from two patients with very low platelet counts, and from one patient with thrombocytosis. PPi levels were also obtained in plasma prepared from blood obtained at uncomplicated venipuncture and in that obtained in a different syringe after trauma to the vein had occurred inadvertently.
Platelet preparations. Washed platelets suspended in 3 mM EDTA, 0.12 M NaCl, 30 mM tris Cl buffer pH 7.4 were prepared according to methods described by Holmsen and Day (5) . Platelet counts were performed by the method of Schweizer and Gerarde (6) . Suspensions containing 6-19.7 X 108 platelets were sonicated with a model W 185
Sonifier cell disruptor, Ultrasonic Inc., Farmingdale, N. Y., at a setting of 7, 4 s X 4 at 40C in the presence of tracer [32pP]Pi. PPi levels were determined on one or more occasions by the yeast PPiase method on platelets obtained from normal donors D. M., D. S., S. J., and D. P., and from N. B. and J. E., patients with osteoarthritis; PPi was also determined in platelets of subject D. S. by the UDPG pyrophosphorylase method and in D. M. and D. S. after chromatographic separation of PPi. In the last instance, and in one sample analyzed by the yeast PPiase method the platelets were sonicated directly in ice-cold 0.5 N TCA after addition of [3P]32Pi tracer.
Release reaction. Thrombin in buffer or buffer alone was added to suspensions of 10.7-19.7 X 10' platelets. Final concentration of thrombin was 5 U/ml. The method was performed exactly as described by Holmsen and Day (5) .
The platelet release reaction induced with thrombin was monitored by measurement of protein, serotonin, and Pglucuronidase in the supernatant and pellet of thrombintreated and control samples. PPi was measured in soluble and sedimentable phases by the yeast PPiase method. Inorganic pyrophosphatase was also measured in both phases. The time course of the release reaction stimulated by thrombin was followed in three experiments using platelets from normal donors. The entire procedure was performed exactly as described by Holmsen Other experiments. Cold ATP was added to tracer 'P gamma-labeled ATP to a final concentration of 0.7 mM and applied to a Dowex-1 column as described for 'PPi (7) . Elution with 200 ml of 0.25 M KCI-0.08 M NH4OH, was followed by 100 ml of 0.2 N HCl.
The possibility of generation of PPi from ATP or other nucleotides by acid hydrolysis during the preparation of the sample for analysis was considered. Thrombin was added to 60 X 108 washed platelets suspended in buffer in the presence of tracer [32P]JPi. After centrifugation, the supernatant was ultrafiltered through Amicon PM 10 membranes (Amicon Corp., Lexington, Mass.), as described previously (7) . PPi was separated chromatographically and analyzed by the UDPG pyrophosphorylase method (vide infra). The PPi content of an ATP solution acidified with TCA (final acid normality=0.5) was determined by UDPG pyrophosphorylase method after coprecipitation of tracer [82P]32Pi with calcium phosphate as described (vide infra), and compared with that in an identical ATP solution not treated with acid. All solutions were maintained at 4VC.
The PPi content of the Pi solution used for coprecipitation was determined by the UDPG pyrophosphorylase method.
Methods of PPi measurement All procedures were performed at 4VC (in crushed ice) except as indicated; all centrifugation steps were carried out in a Sorvall RC-2 centrifuge, Ivan Sorvall, Inc., Norwalk, Conn., unless otherwise specified.
[32P]32Piwascounted in 0.5 N HCl as Cerenkov radiation in a Packard tricarb liquid scintillation counter (Packard Instrument Co., Inc., Downers Grove, Ill.) with correction for background, and for quenching if indicated. All spectrophotometric measurements were made in a Beckman DU spectrophotometer (Beckman Instruments, Inc., Fullerton, Calif.) equipped with a Gilford model 210 absorbance indicator and a model 222 automatic cuvette changer (Gilford Instrument Laboratories, Inc., Oberlin, Ohio).
Yeast PPiase method. Details of this procedure will be published elsewhere (1) . Briefly, the material to be analyzed was collected into a plastic container in ice containing a tracer amount of [32P]32Pi. Inorganic orthophosphate and protein were removed using a modification of the technique of Sugino and Miyoshi (8); the residual Pi and water sufficient to concentrate the sample approximately 10-fold were extracted with isobutanol. After adjustment of the pH to 7.2, aliquots of sample were then incubated at room temperature with either yeast PPiase in buffer or with buffer alone. The Pi in both samples was then determined using a modification of the Chen method (9). Corrections were made for incomplete enzyme action and for loss of PPi due to spontaneous hydrolysis in the buffertreated sample. The PPi concentration in the original sample was then calculated by isotopic dilution. [3'P] "Pi/'Pi was determined in 50 Al of final sample by using the isobutanolpetroleum ether extraction method described by Hall (11) as adapted by Russell and co-workers (4). The specificity of the reaction was confirmed by incubation of an aliquot of the final sample with yeast PPiase.
Column chromatographic method. This was performed using anion exchange resin as previously described (7) as an additional independent check on the specificity of identification. 10-ml fractions were collected and the PPi peak identified by "P counts. PPi was determined by a modified Chen method after hydrolysis by boiling aliquots from each fraction in screw top tubes for 30 min after acidification with HCl (final concentration 1.1 N). In addition, the PPi in 5 ml of each of the fractions in the PPi peak was coprecipitated by addition of Ca and Pi. After a second coprecipitation, the calcium was exchanged for sodium and PPi measured by the UDPG pyrophosphorylase method as described above. The specific activity of ['P]S'Pi was calculated for each fraction, and the PPi concentration was determined in the original sample by isotopic dilution.
Other methods. 5 hydroxytryptamine (Serotonin) was measured spectrofluorometrically by the method of Crosti and Lucchelli (12) . One drop of 3% H202 was added to each sample before rescanning as suggested by Contractor (13) . This treatment reduced each sample to base line on rescanning (blank value). -glhicuronidase was determined by a modification of the method of Baehner, Karnovsky, and Karnovsky (14) . Protein was measured by the method of Lowry, Rosebrough, Farr, and Randall (15) . Calcium was measured by atomic absorption spectrophotometry.
Inorganic pyrophosphatase was determined in samples dialyzed at 9'C against three changes of 10 mM barbital buffer, pH 7.7, containing 1 mM MgCl2, 0.2 mM EDTA, 1 mM mercaptoethanol, penicillin 100 U/ml, and streptomycin 100 ,g/ml. Protein was determined and dilutions made in barbital buffer to give protein concentrations of 250-500 Mg/ml sample. The reaction mixture contained 40 ,uM sodium pyrophosphate, 50 MM MgCl2, tracer ["P]"Pi in 10 mM barbital buffer pH 7.7; 100 Ml of dialysate was added to 0.9 ml reaction mixture and incubated for 0, 3, 5 min at 370C. At the end of incubation the reaction was stopped by placing the tube in ice and adding the acid reagent described by Hall (11) . After all reactions were complete, Pi was extracted with butanol-petroleum ether (11) ; the 32Pi in the butanol phase and the ["2P]"2Pi remaining in the aqueous phase were counted. Reaction mixture run with buffer alone served as control.
RESULTS
Plasma vs. serum PPi. Serum PPi concentrations were two-to threefold higher than those found in plasma prepared from identical blood (Table I) . Plasma and serum PPi from two patients with thrombocytopenia were similar whereas plasma PPi from a patient with thrombocytosis was high but showed the expected increase in the serum. The PPi level in plasma prepared from blood obtained at uncomplicated venipuncture was lower than that in a sample prepared from blood obtained after trauma to the vein had occurred (2.7 vs. 3.9 MM).
Platelet PPi concentrations. PPi was found in human platelets by each of the three analytical methods used, in concentrations of 1.4-3.1 nmol/108 cells (Table II) . All three methods yielded values of the same order of magnitude. The specific activities of ['P]3'Pi in the three major fractions of the PPi peak obtained on column chromatography were 4,500, 4,200, and 3,800 cpm/nmol PPi. The identity of the material eluted with ["P]'Pi was confirmed by a duplicate analysis using the UDPG pyrophosphorylase method (Table II) . Incubation of an aliquot of eluate with yeast inorganic pyrophosphatase abolished the reaction on subsequent analysis by the UDPG pyrophosphorylase method. PPi release from platelets after thrombin stimulation. Approximately 50-60% of platelet PPi was released into the supernate after thrombin stimulation; serotonin and P-glucuronidase were released with respect to control, confirming that the release reaction had occurred (Table  III) . The "specific activity" of the released substances, calculated with respect to supernate protein as suggested by Holmsen and Day (5) , indicated secretion of these substances by platelets and not nonspecific cellular disruption.
Inorganic Pyrophosphate in Human Platelets
A neutrally active, Mg"+-dependent, inorganic pyrophosphatase in platelets was originally described by Datta and Zajicek (16) . This enzyme was not released in detectable amounts after thrombin stimulation (Table  III and Fig. 1 ).
Time course of PPi release after thrombin stimulation. In time course experiments, about 45% of platelet PPi was released extracellularly within 3 s after the addition of thrombin (Fig. 1) . There was a suggestion of a modest secondary rise of 5-8%. Over 80% of serotonin and calcium were released within the first 3 s and no further rise occurred. In contrast, only about 25% of P-glucuronidase was released even after 5 min, and only about one-third of this occurred in the first 3 s. No release of inorganic pyrophosphatase was detected in any sample.
Studies on platelets with nucleotide storage defect. The platelets from two patients with this syndrome contained very low to undetectable amounts of PPi compared with control platelets (Table IV) . The PPi content of the control was also somewhat reduced, possibly due to hydrolysis accompanying thawing. The platelets of another such patient failed to release PPi after thrombin stimulation (0.73 nmol in control supernate vs. 0.75 nmol in thrombin supernate) compared with control platelets processed identically (0.34 nmol in control supernate vs. 1.4 nmol in thrombin supernatant). platelets, values approximating their ADP concentrations and about one-half that of their ATP content as reported by others (6, 17, 20) . Assuming a platelet mass of 0.5% of the blood volume (21) , this represents a PPi concentration of over 800 times that found in normal plasma by the pyrophosphatase method (mean = 1.8 /iM). About 50-60% of platelet PPi appeared in the supernate after stimulation of platelets with thrombin, an amount proportional to reported release of ADP after such stimulation (5). Platelets contain a potent inorganic pyrophosphatase which is not released on thrombin stimulation, suggesting the existence of a pool of intracellular PPi normally inaccessible to enzyme action. As PPi is liberated extracellularly during the release reaction, it is probably stored in an intracellular granule, as has been postulated for other substances participating in the release reaction (5) . The amount and rate of PPi release resembled that reported for ADP by Holmsen and Platelets from this patient are described in reference 17. § Platelets from this patient are described in references 18 and 19. Day. Time course experiments clearly showed a pattern that differed from that of the lysosomal enzyme P-glucuronidase and from calcium or serotonin (Fig. 1) . The finding of low to absent PPi in platelets from patients with known deficiency in nucleotide storage pool suggests that PPi is stored in the same granule as "nonmetabolic" ATP and ADP. Further study of the stoichiometric relationships of storage pool nucleotides, PPi, and calcium are indicated. The practical importance of these observations is that blood or other fluids and tissues to be analyzed for PPi must be obtained with minimal trauma and platelets effectively separated before analysis -or falsely high values may result. The high values for serum PPi reported by Solomons and Styner for example, probably reflect platelet PPi, at least in part (22) . Whether platelet PPi has a significant physiological role as do ADP and ATP, remains to be determined. The present study suggests the existence of an intracellular sequestered pool of PPi in mammalian tissue, although PPi has been found complexed with calcium and magnesium in the intracellular ("volutin") granules of Tetrahymena pyriformis (23) .
